Naltrexone methobromide
- Level
- Commodity
- Parent
- 51142300
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142318This classification denotes an opiate antagonist with the molecular formula C21H26NO4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RFO6IL3D3M, chemically known as morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, bromide, (5.alpha.)-, but more generally known as naltrexone methobromide, which bears US NIH Compound Identifier 5361917. European Medicines Agency schedules naltrexone methobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09143MIG. Most nations, for tariff purposes, schedule naltrexone methobromide under HS 29391900. SMILES: C[N+]1(CC[C@]23C4C5CCC(C4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC6CC6.[BR-].
Same parent
Under 51142300 · 15Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.